Molecular Partners AG -ADRMOLN
13F holders, Q4 2024 (December 31)5holders
0new positions
0sold out
$4.76avg. 13F price*
At the end of Q4 2024, 5 institutions reported holding Molecular Partners AG -ADR (MOLN) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holders were Montanova Capital, LLC ($10.5M), BVF Inc. ($6.5M) and UBS Group AG ($33K).
- Company
- Molecular Partners AG -ADR
- CUSIP
- 60853G106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 2,733,867 shares bought and 133 shares sold, net +2,733,734 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Montanova Capital, LLC | 0.39% | Add +455.4% | 2,221,494 | $10.5M |
| BVF Inc. | 0.22% | Add +205.5% | 1,353,968 | $6.5M |
| UBS Group AG | 0.00% | Add +31.0% | 6,872 | $33K |
| Morgan Stanley | 0.00% | Reduce -26.6% | 367 | $2K |
| Rhumbline Advisers | 0.00% | No change | 269 | $1K |
"% of holder's portfolio" is MOLN's weight in each manager's 13F, not the share of Molecular Partners AG -ADR the manager owns.